The Minimally Invasive Spine Surgery Market is being driven by Increasing incidence of spinal disorders
The Minimally Invasive Spine Surgery Market is expected to grow at a CAGR of 8.4% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1624.9 million. The integration of artificial intelligence (AI) and robotics in minimally invasive spine surgery has significantly transformed the global market by introducing unprecedented levels of precision and efficiency. These advanced technologies have revolutionized surgical planning and execution, offering surgeons enhanced visualization, real-time feedback, and unparalleled accuracy. With AI-driven preoperative imaging analysis, intraoperative navigation, and robotic-assisted precision, complex spinal interventions can be executed with minimal risk of iatrogenic injury and enhanced patient safety. The benefits of these technologies extend beyond improved patient outcomes, as they also facilitate faster recovery times and reduced healthcare costs. The incorporation of AI and robotics in minimally invasive spine surgery represents a pivotal shift in the industry, offering a competitive edge to healthcare providers and driving market growth.
Get more information on Minimally Invasive Spine Surgery Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
186 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.4% |
Market growth 2025-2029 |
USD 1624.9 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
7.8 |
Key countries |
US, Germany, China, Canada, France, Japan, India, UK, South Korea, and Italy |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Minimally Invasive Spine Surgery (MISS) market encompasses innovative technologies and techniques for spine stabilization, spinal decompression, vertebral augmentation, spinal cord stimulation, radiofrequency ablation, and nerve blocks. Advanced imaging, 3D modeling, and virtual reality simulation facilitate surgical training and precision surgery. Biocompatible materials, personalized medicine, and minimally invasive instrumentation ensure patient safety and functional assessment. Surgical workflow optimization, reduced operative time, and blood loss, as well as lower complication rates, are key benefits. Evidence-based medicine, clinical practice guidelines, health economics, value-based care, remote monitoring, artificial intelligence, machine learning, and big data analytics drive data-driven decision making in MISS.
The Minimally Invasive Spine Surgery (MISS) market is a significant segment of the global life science tools and services industry. This market encompasses companies and solutions focused on R&D, manufacturing, and delivery of minimally invasive spinal fusion, spinal stenosis treatment, and herniated disc repair technologies. Key drivers for the MISS market's growth include the increasing global population aging, with a rising number of individuals over 60 years old, and the subsequent surge in degenerative disc disease and spinal stenosis cases. As a result, the demand for less invasive, more efficient, and cost-effective surgical procedures is escalating. The global life science tools and services market, which includes the revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and MISS solutions, is expected to experience substantial growth due to these demographic and healthcare trends.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted